Innovating Works

UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN

Desconocido
Mostrando 1 al 20 de 33 resultados
EASIGEN-DS: DESIGN STUDY FOR A EUROPEAN INFRASTRUCTURE ON ADVANCED GENOMICS TECHNOLOGIES UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-INFRA-2024-DEV-01 Innovation in the genomics field is extremely intense and requires high up-front investments. The toolbox of sequencing platforms with uniqu...
2024-10-09 - 2028-01-31 | Financiado
DANIO-ReCODE: DANIO CODE the next frontier Decoding transcription regulation in regeneration by advanced genomi... The principal objective of DANIO-ReCODE is to provide world-class doctoral training to a new generation of early-career researchers interest...
2024-07-09 - 2028-10-31 | Financiado
RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network Excellence through Systems Biology Spatial and... UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2024-07-01 - 2029-02-28 | Financiado
PROMOTE: PRostate cancer OMics Oriented inTErvention PROMOTE focuses on multidisciplinary education of doctoral candidates (DCs) in -omics and artificial intelligence (AI) mediated intervention...
2024-06-24 - 2028-08-31 | Financiado
RESPONSE: Early detection of treatment response in breast cancer UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-EIC-2023-TRANSITION-01 Breast cancer is the prominent cancer among women globally, with over 2 million women diagnosed annually. Even though early detection and ad...
2024-03-20 - 2027-05-31 | Financiado
VESICULOME: Origin, evolution and function of bacterial extracellular vesicles in the human host-gut microbiome... UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: ERC-2023-COG Bacterial extracellular vesicles (BEVs) are small membrane vesicles secreted by a diverse range of bacteria that act as bioactive nanocarrie...
2024-03-19 - 2029-05-31 | Financiado
SCIENCE4FUTURE: SCIENCE4FUTURE: FESTIVAL DER WISSENSCHAFT KIEL REGION 2024/2025 UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-MSCA-2023-CITIZENS-01 Approaching its 10th anniversary in 2025, the hugely popular European Researchers’ Night will return in 2024/25 to the Kiel region as a true...
2024-03-12 - 2025-12-31 | Financiado
TanyCilia: The role of tanycytic cilia in hypothalamic functions. UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Obesity and metabolic diseases are a top priority challenge for health systems. Monitoring changes in the body’s energy levels is a task of...
2024-03-05 - 2026-03-31 | Financiado
IgG4-TREAT: Systematic study of IgG4-autoimmune diseases to develop new treatment strategies UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 IgG4-autoimmune diseases (IgG4-AID) are rare but collectively correspond to a significant group of devastating diseases affecting many diffe...
2023-07-07 - 2027-08-31 | Financiado
MRStain: Non-invasive staining of tissue microstructure in temporal lobe epilepsy using in- vivo MRI UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: ERC-2022-COG Ex-vivo histology is the gold standard to investigate human brain microstructure. However, its invasive nature precludes its use in monitori...
2023-05-19 - 2029-06-30 | Financiado
ARTiDe: Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, with a risk of devastating complications, premature mortality, a...
2023-04-27 - 2028-06-30 | Financiado
miGut-Health: Personalised blueprint intestinal health UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease....
2023-01-01 - 2026-12-31 | Financiado
PANCAID: PANcreatic CAncer Initial Detection via liquid biopsy UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 Pancreatic cancer (PDAC) is usually detected at late stages and most patients die within one year after diagnosis. In PANCAID we will theref...
2022-12-02 - 2027-12-31 | Financiado
ONCOSCREEN: A European shield against colorectal cancer based on novel, more precise and affordable risk-based s... UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in scre...
2022-11-28 - 2026-12-31 | Financiado
MicroT: Microbiota-T cell interactions - antigen-specificity and regulation in health and disease UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: ERC-2021-STG The microbiota has an enormous influence on human health. CD4+ T cells play a central role in controlling the interaction with the microbiot...
2022-06-23 - 2027-06-30 | Financiado
environMENTAL: Reducing the impact of major environmental challenges on mental health The environMENTAL project will investigate how some of the greatest global environmental challenges, climate change, urbanisation, and psych...
2022-05-23 - 2027-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.